Tarsus Pharmaceuticals, Inc. - Common Stock (TARS)
CUSIP: 87650L103
Q1 2026 13F Holders as of 31 Mar 2026
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 42,450,857
- Total 13F shares
- 1,998,112
- Share change
- +186,403
- Total reported value
- $140,072,480
- Price per share
- $70.15
- Number of holders
- 46
- Value change
- +$12,857,148
- Number of buys
- 23
- Number of sells
- 16
Quarterly Holders Quick Answers
What is CUSIP 87650L103?
CUSIP 87650L103 identifies TARS - Tarsus Pharmaceuticals, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Previous quarter: Q4 2025
Recent filing periods for CUSIP 87650L103:
Top shareholders of TARS - Tarsus Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
|
Company |
7.4%
from 13D/G
|
3,790,557
|
$310,370,807 | — | 31 Dec 2025 | |
| RTW INVESTMENTS, LP |
13F
13D/G
3/4/5
|
Company · 10%+ Owner |
8.1%
from 13D/G
|
3,335,320
|
$273,096,002 | — | 31 Dec 2025 | |
| Deep Track Capital, LP |
13F
13D/G
|
Company |
7.1%
from 13D/G
|
3,004,034
|
$245,970,304 | — | 31 Dec 2025 | |
| Paradigm Biocapital Advisors LP |
13F
|
Company |
6%
|
2,562,154
|
$209,789,170 | — | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.7%
|
2,399,560
|
$196,475,972 | — | 31 Dec 2025 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
5.3%
|
2,230,069
|
$182,598,052 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
13D/G
|
Company |
4.7%
from 13D/G
|
2,040,742
|
$167,095,971 | — | 31 Dec 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
4.5%
|
1,930,325
|
$158,062,427 | — | 31 Dec 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
13D/G
|
Company |
2.8%
from 13D/G
|
1,188,624
|
$97,324,533 | — | 31 Dec 2025 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.8%
|
1,172,427
|
$95,998,323 | — | 31 Dec 2025 | |
| Cowen Financial Products LLC |
13D/G
|
— |
4.9%
|
1,909,228
|
$94,926,816 | $0 | 31 Dec 2024 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
2.7%
|
1,127,730
|
$92,338,532 | — | 31 Dec 2025 | |
| Invesco Ltd. |
13F
|
Company |
2.4%
|
1,012,357
|
$82,891,790 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.2%
|
947,763
|
$77,616,160 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
2.2%
|
929,059
|
$76,071,351 | — | 31 Dec 2025 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
2%
|
855,645
|
$70,060,000 | — | 31 Dec 2025 | |
| Bobak R. Azamian |
3/4/5
|
President/CEO and Board Chair, Director |
—
mixed-class rows
|
1,032,769
mixed-class rows
|
$62,840,902 | -$3,492,213 | 17 Mar 2026 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.8%
|
758,106
|
$62,073,719 | — | 31 Dec 2025 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
1.7%
|
728,644
|
$59,661,371 | — | 31 Dec 2025 | |
| FMR LLC |
13F
|
Company |
1.5%
|
647,114
|
$52,985,671 | — | 31 Dec 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.4%
|
615,156
|
$50,368,973 | — | 31 Dec 2025 | |
| Vivo Capital IX, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,469,001
|
$49,380,020 | — | 05 May 2022 | |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. |
13F
|
Company |
1.4%
|
584,686
|
$47,874,000 | — | 31 Dec 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.2%
|
518,780
|
$42,479,000 | — | 31 Dec 2025 | |
| TORONTO DOMINION BANK |
13F
|
Company |
1.2%
|
510,253
|
$41,779,516 | — | 31 Dec 2025 | |
| Clearbridge Investments, LLC |
13F
|
Company |
1.2%
|
506,089
|
$41,438,557 | — | 31 Dec 2025 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
1.1%
|
474,050
|
$38,815,214 | — | 31 Dec 2025 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
1%
|
441,873
|
$36,180,561 | — | 31 Dec 2025 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
1%
|
436,576
|
$35,746,843 | — | 31 Dec 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.95%
|
401,241
|
$32,853,613 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.89%
|
378,704
|
$31,008,283 | — | 31 Dec 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.84%
|
356,105
|
$29,157,877 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.81%
|
342,486
|
$28,042,754 | — | 31 Dec 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.79%
|
337,016
|
$27,594,870 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.78%
|
333,111
|
$27,275,129 | — | 31 Dec 2025 | |
| TimesSquare Capital Management, LLC |
13F
|
Company |
0.78%
|
332,446
|
$27,220,678 | — | 31 Dec 2025 | |
| MPM BioImpact LLC |
13F
|
Company |
0.77%
|
328,869
|
$26,927,794 | — | 31 Dec 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.76%
|
322,527
|
$26,408,511 | — | 31 Dec 2025 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.61%
|
260,344
|
$21,316,967 | — | 31 Dec 2025 | |
| Cormorant Asset Management, LP |
13F
|
Company |
0.59%
|
250,000
|
$20,470,000 | — | 31 Dec 2025 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.47%
|
200,000
|
$16,376,000 | — | 31 Dec 2025 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.41%
|
173,275
|
$14,187,757 | — | 31 Dec 2025 | |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND |
13F
|
Company |
0.38%
|
161,830
|
$13,250,640 | — | 31 Dec 2025 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.36%
|
154,400
|
$12,642,272 | — | 31 Dec 2025 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.36%
|
153,760
|
$12,589,963 | — | 31 Dec 2025 | |
| CANADA PENSION PLAN INVESTMENT BOARD |
13F
|
Company |
0.36%
|
151,100
|
$12,372,068 | — | 31 Dec 2025 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
0.31%
|
130,380
|
$10,530,792 | — | 31 Dec 2025 | |
| Jump Financial, LLC |
13F
|
Company |
0.3%
|
128,087
|
$10,487,763 | — | 31 Dec 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.28%
|
119,058
|
$9,748,469 | — | 31 Dec 2025 | |
| Jefferies Financial Group Inc. |
13F
|
Company |
0.28%
|
118,810
|
$9,728,163 | — | 31 Dec 2025 |
Institutional Holders of Tarsus Pharmaceuticals, Inc. - Common Stock (TARS) as of Q1 2026
As of 31 Mar 2026,
Tarsus Pharmaceuticals, Inc. - Common Stock (TARS) was held by
46 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,998,112 shares.
The largest 10 holders included
Assenagon Asset Management S.A., Nuveen, LLC, COMMONWEALTH EQUITY SERVICES, LLC, Calamos Advisors LLC, E. Ohman J:or Asset Management AB, Pictet Asset Management Holding SA, HARBOR CAPITAL ADVISORS, INC., Capricorn Fund Managers Ltd, WEDGE CAPITAL MANAGEMENT L L P/NC, and SG Americas Securities, LLC.
This page lists
50
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
245
Q1 2026 holders
46
Holder diff
-199
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.